Ming Gao - Concepedia

Author

Ming Gao

Tianjin Medical University Cancer Institute and Hospital ORCID

Also Known As

Gao Ming, Gao, Ming, M Gao, M. Gao, MING GAO, Meng-meng GAO, Min Gao, Ming GAO, Ming Gao, Mingchi Gao

155

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Tianjin Medical University Cancer Institute and Hospital Zhengzhou University National Clinical Research Chinese Academy of Medical Sciences & Peking Union Medical College Henan Cancer Hospital

About

Ming Gao is an author at Tianjin Medical University Cancer Institute and Hospital specializing in medicine, pharmacology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	380
2	Health Sciences	4	4	120
3	Cell Biology	4	4	160
4	Biochemistry	3	3	93
5	Public Health	1	1	62

Ming Gao

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity Weilie Chen, Yun Lan, Xiao-zhen Yuan, Emerging Microbes & Infections	2020	407
Anlotinib for the Treatment of Patients with Locally Advanced or Metastatic Medullary Thyroid Cancer Yongkun Sun, Feng Du, Ming Gao, Thyroid	2018	109
Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial Dapeng Li, Yihebali Chi, Xiaohong Chen, Clinical Cancer Research	2021	108
Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer Francis P. Worden, Yuankai Shi, Tatiana Hadjieva, Endocrine Related Cancer	2015	65
Association between iron status and the risk of adverse outcomes in COVID-19 Yanling Lv, Liangkai Chen, Xiaoling Liang, Clinical Nutrition Preventive MedicineEpidemiological OutcomeDisease Risk AssessmentCovid-19 PandemicClinical Epidemiology	2020	62
Quercetin overcomes colon cancer cells resistance to chemotherapy by inhibiting solute carrier family 1, member 5 transporter Yuanyuan Zhou, Jun Zhang, Kaili Wang, European Journal of Pharmacology OncologyMedicineAnti-cancer AgentMember 5Cancer Treatment	2020	57
Secondary interaction between MDMX and p53 core domain inhibits p53 DNA binding Xi Wei, Shaofang Wu, Tanjing Song, Proceedings of the National Academy of Sciences	2016	50
Dual Phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancer Yu‐Hsuan Chen, Ming-Feng Wei, Chun-Wei Wang, Cancer Letters Rapamycin InhibitorMedicineColorectal CancerAnti-cancer AgentCell Biology	2014	49
Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto’s thyroiditis Y. Liu, Xinwei Yun, Ming Gao, Clinical & Translational Oncology Hashimoto ’MedicineThyroid DiseaseImmunologyT-regulatory Cell	2014	47
Hepatoprotective effects of oridonin against bisphenol A induced liver injury in rats via inhibiting the activity of xanthione oxidase Xinying Wang, Ming Gao, Zihan Wang, The Science of The Total Environment HepatologyBiochemistryLiver InjuryXanthione OxidaseLiver Physiology	2021	41

Page 1